Study: J&J's stent better than Boston Scientific's

09/13/2007 | NYTimes.com

Patients who received Johnson & Johnson's Cypher drug-coated stent were less likely to suffer heart attacks than patients who received Boston Scientific Corp.'s Taxus stent and bare-metal stents, a study revealed. Researchers also found that Taxus stents slightly increased the risk of fatal clots in patients compared with Cypher and bare-metal stents.

View Full Article in:

NYTimes.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Actuary
Meridian Health Plan
Detroit, MI
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Director, Payer Marketing
Avalere Health
Washington, DC
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC